158 related articles for article (PubMed ID: 34526543)
1. CRISPR/Cas9 small promoter deletion in H19 lncRNA is associated with altered cell morphology and proliferation.
da Silva Santos R; Pinheiro DP; Teixeira LPR; Sales SLA; Dos Santos Luciano MC; de Lima Melo MM; Pinheiro RF; Tavares KCS; Furtado GP; Pessoa C; Furtado CLM
Sci Rep; 2021 Sep; 11(1):18380. PubMed ID: 34526543
[TBL] [Abstract][Full Text] [Related]
2. Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research.
Zhen S; Li X
Hum Gene Ther; 2019 Jan; 30(1):3-9. PubMed ID: 30045635
[TBL] [Abstract][Full Text] [Related]
3. A Cohesin-Mediated Intrachromosomal Loop Drives Oncogenic ROR lncRNA to Accelerate Tumorigenesis.
Fan J; Xu Y; Wen X; Ge S; Jia R; Zhang H; Fan X
Mol Ther; 2019 Dec; 27(12):2182-2194. PubMed ID: 31451355
[TBL] [Abstract][Full Text] [Related]
4. H19 lncRNA: Roles in tumorigenesis.
Ghafouri-Fard S; Esmaeili M; Taheri M
Biomed Pharmacother; 2020 Mar; 123():109774. PubMed ID: 31855739
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
[TBL] [Abstract][Full Text] [Related]
6. The double-edged sword of H19 lncRNA: Insights into cancer therapy.
Shermane Lim YW; Xiang X; Garg M; Le MT; Li-Ann Wong A; Wang L; Goh BC
Cancer Lett; 2021 Mar; 500():253-262. PubMed ID: 33221454
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter.
Gao LM; Xu SF; Zheng Y; Wang P; Zhang L; Shi SS; Wu T; Li Y; Zhao J; Tian Q; Yin XB; Zheng L
J Cell Mol Med; 2019 Sep; 23(9):6411-6428. PubMed ID: 31317666
[TBL] [Abstract][Full Text] [Related]
8. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
[TBL] [Abstract][Full Text] [Related]
9. Expression and role of long non-coding RNA H19 in carcinogenesis.
Yoshimura H; Matsuda Y; Yamamoto M; Kamiya S; Ishiwata T
Front Biosci (Landmark Ed); 2018 Jan; 23(4):614-625. PubMed ID: 28930564
[TBL] [Abstract][Full Text] [Related]
10. The Interplay of LncRNA-H19 and Its Binding Partners in Physiological Process and Gastric Carcinogenesis.
Zhang L; Zhou Y; Huang T; Cheng AS; Yu J; Kang W; To KF
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230721
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer.
Zhu Z; Song L; He J; Sun Y; Liu X; Zou X
Int J Clin Exp Pathol; 2015; 8(9):10082-91. PubMed ID: 26617715
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-mediated deletion of lncRNA Gm26878 in the distant Foxf1 enhancer region.
Szafranski P; Karolak JA; Lanza D; Gajęcka M; Heaney J; Stankiewicz P
Mamm Genome; 2017 Aug; 28(7-8):275-282. PubMed ID: 28405742
[TBL] [Abstract][Full Text] [Related]
13. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-mediated gene editing on Sox2ot promoter leads to its truncated expression and does not influence neural tube closure and embryonic development in mice.
Li PY; Li SQ; Gao SG; Dong DY
Biochem Biophys Res Commun; 2021 Oct; 573():107-111. PubMed ID: 34403806
[TBL] [Abstract][Full Text] [Related]
15. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.
Singh N; Padi SKR; Bearss JJ; Pandey R; Okumura K; Beltran H; Song JH; Kraft AS; Olive V
Mol Oncol; 2020 May; 14(5):974-990. PubMed ID: 32146726
[TBL] [Abstract][Full Text] [Related]
16. Kaiso mediates human ICR1 methylation maintenance and H19 transcriptional fine regulation.
Bohne F; Langer D; Martiné U; Eider CS; Cencic R; Begemann M; Elbracht M; Bülow L; Eggermann T; Zechner U; Pelletier J; Zabel BU; Enklaar T; Prawitt D
Clin Epigenetics; 2016; 8():47. PubMed ID: 27152123
[TBL] [Abstract][Full Text] [Related]
17. The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer.
Singh N; Ramnarine VR; Song JH; Pandey R; Padi SKR; Nouri M; Olive V; Kobelev M; Okumura K; McCarthy D; Hanna MM; Mukherjee P; Sun B; Lee BR; Parker JB; Chakravarti D; Warfel NA; Zhou M; Bearss JJ; Gibb EA; Alshalalfa M; Karnes RJ; Small EJ; Aggarwal R; Feng F; Wang Y; Buttyan R; Zoubeidi A; Rubin M; Gleave M; Slack FJ; Davicioni E; Beltran H; Collins C; Kraft AS
Nat Commun; 2021 Dec; 12(1):7349. PubMed ID: 34934057
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer.
Li H; Yu B; Li J; Su L; Yan M; Zhu Z; Liu B
Oncotarget; 2014 Apr; 5(8):2318-29. PubMed ID: 24810858
[TBL] [Abstract][Full Text] [Related]
19. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.
Wang J; Xie S; Yang J; Xiong H; Jia Y; Zhou Y; Chen Y; Ying X; Chen C; Ye C; Wang L; Zhou J
J Hematol Oncol; 2019 Jul; 12(1):81. PubMed ID: 31340867
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy.
Hashemi M; Moosavi MS; Abed HM; Dehghani M; Aalipour M; Heydari EA; Behroozaghdam M; Entezari M; Salimimoghadam S; Gunduz ES; Taheriazam A; Mirzaei S; Samarghandian S
Pharmacol Res; 2022 Oct; 184():106418. PubMed ID: 36038043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
